Featured Headlines Feed for PSTI Headlines for PLURISTEM THERAPEUTICS, INC. http://www.rssboard.org/rss-specification Argotic Syndication Framework 2008.0.2.0, http://www.codeplex.com/Argotic A Focus On Stem-Cell Therapy And Regenerative Medicine For 2013 http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1447161-a-focus-on-stem-cell-therapy-and-regenerative-medicine-for-2013.aspx?source=itxwebtxt0000015 Seeking Alpha Mon, 20 May 2013 11:38:55 GMT Cloning: A Stem Cell Revolution? http://www.fool.com/news/xt/aol-daily-finance/www.dailyfinance.com/2013/05/19/cloning-a-stem-cell-revolution/.aspx?source=itxwebtxt0000015 DailyFinance Sun, 19 May 2013 11:52:00 GMT A Peek Into The Market Before The Trading Starts http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3564768/a-peek-into-the-market-before-the-trading-starts.aspx?source=itxwebtxt0000015 Benzinga Tue, 07 May 2013 07:19:57 GMT Pluristem Announces First Clinical Indication for PLX-RAD Cells for Use in Hematology http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/05/3564404/pluristem-announces-first-clinical-indication-for-plx-rad-cells-for-use-in-hemato.aspx?source=itxwebtxt0000015 Benzinga Tue, 07 May 2013 05:54:53 GMT United Therapeutics' Second PAH Stumble Emphasizes The Need For Pluristem's Therapy http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1383441-united-therapeutics-second-pah-stumble-emphasizes-the-need-for-pluristem-s-therapy.aspx?source=itxwebtxt0000015 Seeking Alpha Tue, 30 Apr 2013 04:19:00 GMT PSTI Plans to Start Phase I Study - Analyst Blog http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97496/psti-plans-to-start-phase-i-study.aspx?source=itxwebtxt0000015 Zacks Fri, 19 Apr 2013 16:00:01 GMT Investing In The Stem Cell Sector: An Overview http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1347281-investing-in-the-stem-cell-sector-an-overview.aspx?source=itxwebtxt0000015 Seeking Alpha Wed, 17 Apr 2013 08:36:00 GMT UTHR to Move PAH Drug into Phase I - Analyst Blog http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/97042/uthr-to-move-pah-drug-into-phase-i.aspx?source=itxwebtxt0000015 Zacks Mon, 15 Apr 2013 11:30:01 GMT United Therapeutics Receives Regulatory Approval to Commence Phase I Study of Pluristem's PLX-PAD Ce http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/earnings/13/04/3488617/united-therapeutics-receives-regulatory-approval-to-commence-phase-i-stu.aspx?source=itxwebtxt0000015 Benzinga Thu, 11 Apr 2013 06:00:32 GMT The Vatican / NeoStem Partnership Looks To Create Interest And Advance Cell Therapy http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1331561-the-vatican-neostem-partnership-looks-to-create-interest-and-advance-cell-therapy.aspx?source=itxwebtxt0000015 Seeking Alpha Wed, 10 Apr 2013 04:00:21 GMT Brainstorm's Breakthrough ALS Clinical Data Shows The Promise In Stem Cell Therapy http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1306501-brainstorm-s-breakthrough-als-clinical-data-shows-the-promise-in-stem-cell-therapy.aspx?source=itxwebtxt0000015 Seeking Alpha Thu, 28 Mar 2013 09:14:47 GMT Pipeline Progress at Pluristem - Analyst Blog http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/95598/pipeline-progress-at-pluristem.aspx?source=itxwebtxt0000015 Zacks Mon, 25 Mar 2013 17:35:01 GMT The Future Of Medicine: A Look At 5 Stem Cell Companies http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1295171-the-future-of-medicine-a-look-at-5-stem-cell-companies.aspx?source=itxwebtxt0000015 Seeking Alpha Fri, 22 Mar 2013 11:58:48 GMT A Peek Into The Market Before The Trading Starts http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3431600/a-peek-into-the-market-before-the-trading-starts.aspx?source=itxwebtxt0000015 Benzinga Wed, 20 Mar 2013 07:35:43 GMT Pluristem Provides Update on Phase I/II Clinical Trial for the Treatment of Muscle Injury http://www.fool.com/news/xt/benzinga/www.benzinga.com/news/13/03/3431183/pluristem-provides-update-on-phase-iii-clinical-trial-for-the-treatment-of-muscle.aspx?source=itxwebtxt0000015 Benzinga Wed, 20 Mar 2013 05:59:31 GMT Phase II Trials Will Be Pivotal For These Stem Cell Companies http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1288311-phase-ii-trials-will-be-pivotal-for-these-stem-cell-companies.aspx?source=itxwebtxt0000015 Seeking Alpha Wed, 20 Mar 2013 03:26:30 GMT Benzinga's Top Initiations http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/initiation/13/03/3427669/benzingas-top-initiations.aspx?source=itxwebtxt0000015 Benzinga Tue, 19 Mar 2013 07:58:17 GMT UPDATE: Jefferies Initiates Pluristem Therapeutics at Hold on Balanced Risk/Reward http://www.fool.com/news/xt/benzinga/www.benzinga.com/analyst-ratings/analyst-color/13/03/3427525/update-jefferies-initiates-pluristem-therapeutics-at-hol.aspx?source=itxwebtxt0000015 Benzinga Tue, 19 Mar 2013 07:27:10 GMT Pluristem & UTHR Progress with PLX-PAD - Analyst Blog http://www.fool.com/news/xt/zacks/www.zacks.com/stock/news/93961/pluristem-uthr-progress-with-plx-pad.aspx?source=itxwebtxt0000015 Zacks Mon, 04 Mar 2013 17:25:01 GMT 2012 Stem Cell Standouts And The Outlook For 2013 http://www.fool.com/news/xt/seekingalpha/seekingalpha.com/article/1234481-2012-stem-cell-standouts-and-the-outlook-for-2013.aspx?source=itxwebtxt0000015 Seeking Alpha Thu, 28 Feb 2013 14:15:44 GMT